These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 19415459)

  • 1. Do resident renal mast cells play a role in the pathogenesis of diabetic nephropathy?
    Balakumar P; Reddy J; Singh M
    Mol Cell Biochem; 2009 Oct; 330(1-2):187-92. PubMed ID: 19415459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathogenic role of mast cells in the development of diabetic nephropathy: a study of patients at different stages of the disease.
    Zheng JM; Yao GH; Cheng Z; Wang R; Liu ZH
    Diabetologia; 2012 Mar; 55(3):801-11. PubMed ID: 22130579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mast cells in human allografted kidney: correlation with interstitial fibrosis.
    Goto E; Honjo S; Yamashita H; Shomori K; Adachi H; Ito H
    Clin Transplant; 2002; 16 Suppl 8():7-11. PubMed ID: 12464125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mast cells and type VIII collagen in human diabetic nephropathy.
    Rüger BM; Hasan Q; Greenhill NS; Davis PF; Dunbar PR; Neale TJ
    Diabetologia; 1996 Oct; 39(10):1215-22. PubMed ID: 8897010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetic nephropathy - is this an immune disorder?
    Tesch GH
    Clin Sci (Lond); 2017 Aug; 131(16):2183-2199. PubMed ID: 28760771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased chymase-positive mast cells in children with crescentic glomerulonephritis.
    Togawa H; Nakanishi K; Shima Y; Obana M; Sako M; Nozu K; Tanaka R; Iijima K; Yoshikawa N
    Pediatr Nephrol; 2009 May; 24(5):1071-5. PubMed ID: 19050935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between oxidative stress and inflammatory cytokines in diabetic nephropathy.
    Elmarakby AA; Sullivan JC
    Cardiovasc Ther; 2012 Feb; 30(1):49-59. PubMed ID: 20718759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammation and the pathogenesis of diabetic nephropathy.
    Wada J; Makino H
    Clin Sci (Lond); 2013 Feb; 124(3):139-52. PubMed ID: 23075333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibroblast growth factor 1 ameliorates diabetic nephropathy by an anti-inflammatory mechanism.
    Liang G; Song L; Chen Z; Qian Y; Xie J; Zhao L; Lin Q; Zhu G; Tan Y; Li X; Mohammadi M; Huang Z
    Kidney Int; 2018 Jan; 93(1):95-109. PubMed ID: 28750927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Globo-series glycosphingolipids enhance Toll-like receptor 4-mediated inflammation and play a pathophysiological role in diabetic nephropathy.
    Nitta T; Kanoh H; Inamori KI; Suzuki A; Takahashi T; Inokuchi JI
    Glycobiology; 2019 Mar; 29(3):260-268. PubMed ID: 30476082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mast cells: the forgotten cells of renal fibrosis.
    Roberts IS; Brenchley PE
    J Clin Pathol; 2000 Nov; 53(11):858-62. PubMed ID: 11127270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pathogenesis of diabetic nephropathy: focus on microRNAs and proteomics.
    Conserva F; Pontrelli P; Accetturo M; Gesualdo L
    J Nephrol; 2013; 26(5):811-20. PubMed ID: 23543479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early intervention with mesenchymal stem cells prevents nephropathy in diabetic rats by ameliorating the inflammatory microenvironment.
    Li Y; Liu J; Liao G; Zhang J; Chen Y; Li L; Li L; Liu F; Chen B; Guo G; Wang C; Yang L; Cheng J; Lu Y
    Int J Mol Med; 2018 May; 41(5):2629-2639. PubMed ID: 29484379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metallothionein deficiency exacerbates diabetic nephropathy in streptozotocin-induced diabetic mice.
    Tachibana H; Ogawa D; Sogawa N; Asanuma M; Miyazaki I; Terami N; Hatanaka T; Horiguchi CS; Nakatsuka A; Eguchi J; Wada J; Yamada H; Takei K; Makino H
    Am J Physiol Renal Physiol; 2014 Jan; 306(1):F105-15. PubMed ID: 24154695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diabetic nephropathy: from mechanisms to rational therapies.
    Giunti S; Barit D; Cooper ME
    Minerva Med; 2006 Jun; 97(3):241-62. PubMed ID: 16855519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NOD2 promotes renal injury by exacerbating inflammation and podocyte insulin resistance in diabetic nephropathy.
    Du P; Fan B; Han H; Zhen J; Shang J; Wang X; Li X; Shi W; Tang W; Bao C; Wang Z; Zhang Y; Zhang B; Wei X; Yi F
    Kidney Int; 2013 Aug; 84(2):265-76. PubMed ID: 23594678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of TNF-alpha in diabetic nephropathy: pathogenic and therapeutic implications.
    Navarro JF; Mora-Fernández C
    Cytokine Growth Factor Rev; 2006 Dec; 17(6):441-50. PubMed ID: 17113815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of Toll-like receptors in diabetic nephropathy.
    Mudaliar H; Pollock C; Panchapakesan U
    Clin Sci (Lond); 2014 May; 126(10):685-94. PubMed ID: 24490813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Wnt signaling and podocyte dysfunction in diabetic nephropathy.
    Bose M; Almas S; Prabhakar S
    J Investig Med; 2017 Dec; 65(8):1093-1101. PubMed ID: 28935636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retinopathy, hematuria, and diabetic nephropathy.
    Izzedine H; Fongoro S; Pajot O; Beaufils H; Deray G
    Nephron; 2001 Aug; 88(4):382-3. PubMed ID: 11474236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.